Changes in Behavior After Vaccination and Opinions Toward Mask Wearing: Thoracic Oncology Patient-Reported Experiences During the COVID-19 Pandemic.
Corona virus
SARS-CoV-2
quarantine
social distancing
thoracic malignancies
Journal
Clinical Medicine Insights. Oncology
ISSN: 1179-5549
Titre abrégé: Clin Med Insights Oncol
Pays: United States
ID NLM: 101525771
Informations de publication
Date de publication:
2022
2022
Historique:
received:
06
04
2022
accepted:
17
08
2022
entrez:
30
9
2022
pubmed:
1
10
2022
medline:
1
10
2022
Statut:
epublish
Résumé
The COVID-19 vaccines, face masks, and social distancing are effective interventions to prevent SARS-CoV-2 infections. In this study, we aimed to determine lung cancer patients' attitudes toward vaccination, changes in behavior after vaccination, and willingness to continue mask wearing after the pandemic. We sent out questionnaires to 220 thoracic oncology patients treated at our lung cancer center in May 2021. The questionnaire focused on patients' vaccination status, self-reported experiences surrounding vaccination, and assessed changes in behaviors before and after vaccination as well as opinions toward mask wearing after the pandemic. Results are presented as absolute and relative frequencies and means with standard deviation and compared using About 91.0% of patients reported having received at least 1 vaccination. About 73.3% of patients reported having at least 1 reaction to the vaccination. The most common reactions were pain at the injection site, fatigue, and headache. After vaccination, patients increased contact with family and friends, use of public transport, and grocery shopping. Overall, the level of willingness to wear masks beyond the end of the pandemic differed according to vaccination status. Acceptance of the COVID-19 vaccination among thoracic oncology patients in Germany was high. Overall, patients with thoracic malignancies tolerated the COVID-19 vaccination well. Rate of adverse reaction was not higher compared with the general population. After the vaccination, patients increased social contacts and usage of public transport. These changes suggest positive psychological effects on quality of life. While reducing social distancing can increase the risk of infection, our results indicate that an extension of mask mandates after the pandemic would likely be accepted by a majority of thoracic oncology patients, suggesting that our cohort was still aware and in support of other measure of protection.
Sections du résumé
Background
UNASSIGNED
The COVID-19 vaccines, face masks, and social distancing are effective interventions to prevent SARS-CoV-2 infections. In this study, we aimed to determine lung cancer patients' attitudes toward vaccination, changes in behavior after vaccination, and willingness to continue mask wearing after the pandemic.
Methods
UNASSIGNED
We sent out questionnaires to 220 thoracic oncology patients treated at our lung cancer center in May 2021. The questionnaire focused on patients' vaccination status, self-reported experiences surrounding vaccination, and assessed changes in behaviors before and after vaccination as well as opinions toward mask wearing after the pandemic. Results are presented as absolute and relative frequencies and means with standard deviation and compared using
Results
UNASSIGNED
About 91.0% of patients reported having received at least 1 vaccination. About 73.3% of patients reported having at least 1 reaction to the vaccination. The most common reactions were pain at the injection site, fatigue, and headache. After vaccination, patients increased contact with family and friends, use of public transport, and grocery shopping. Overall, the level of willingness to wear masks beyond the end of the pandemic differed according to vaccination status.
Conclusions
UNASSIGNED
Acceptance of the COVID-19 vaccination among thoracic oncology patients in Germany was high. Overall, patients with thoracic malignancies tolerated the COVID-19 vaccination well. Rate of adverse reaction was not higher compared with the general population. After the vaccination, patients increased social contacts and usage of public transport. These changes suggest positive psychological effects on quality of life. While reducing social distancing can increase the risk of infection, our results indicate that an extension of mask mandates after the pandemic would likely be accepted by a majority of thoracic oncology patients, suggesting that our cohort was still aware and in support of other measure of protection.
Identifiants
pubmed: 36176285
doi: 10.1177/11795549221123618
pii: 10.1177_11795549221123618
pmc: PMC9515761
doi:
Types de publication
Journal Article
Langues
eng
Pagination
11795549221123618Informations de copyright
© The Author(s) 2022.
Déclaration de conflit d'intérêts
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Eur Respir J. 2022 Mar 31;59(3):
pubmed: 34475232
Vaccines (Basel). 2021 Apr 21;9(5):
pubmed: 33919048
Exp Gerontol. 2021 Jul 15;150:111349
pubmed: 33892133
Cancers (Basel). 2021 Aug 01;13(15):
pubmed: 34359783
Lancet Oncol. 2021 May;22(5):581-583
pubmed: 33812495
J Investig Med. 2021 Dec;69(8):1426-1433
pubmed: 34315800
Vaccines (Basel). 2021 Sep 19;9(9):
pubmed: 34579281
PLoS One. 2021 Sep 8;16(9):e0256406
pubmed: 34496006
Vaccines (Basel). 2021 Nov 03;9(11):
pubmed: 34835207
J Immunother Cancer. 2021 Mar;9(3):
pubmed: 33737345
Hum Vaccin Immunother. 2022 Dec 31;18(1):2022920
pubmed: 35061569
Respir Res. 2022 Jan 29;23(1):18
pubmed: 35093079
Cancer Discov. 2020 Jun;10(6):783-791
pubmed: 32345594
Nature. 2020 May 21;:
pubmed: 32440021
Lancet Oncol. 2021 Dec;22(12):1681-1691
pubmed: 34767759
Med Decis Making. 2021 Nov;41(8):988-1003
pubmed: 34041970
JMIRx Med. 2021 Aug 12;2(3):e29324
pubmed: 34424255
Cancers (Basel). 2021 Jul 16;13(14):
pubmed: 34298785
Clin Infect Dis. 2021 Dec 16;73(12):2257-2264
pubmed: 33515252
Lancet. 2020 Jun 20;395(10241):1907-1918
pubmed: 32473681
Future Oncol. 2021 Sep;17(26):3477-3484
pubmed: 34189948
J Card Surg. 2020 Jun;35(6):1345-1347
pubmed: 32419177
Allergy. 2021 Feb;76(2):428-455
pubmed: 33185910
PLoS One. 2020 Apr 16;15(4):e0231924
pubmed: 32298385
Ann Oncol. 2022 Mar;33(3):340-346
pubmed: 34958894
Eur J Cancer. 2018 Nov;104:182-187
pubmed: 30368069
Prev Chronic Dis. 2021 Jul 01;18:E66
pubmed: 34197283
Proc Natl Acad Sci U S A. 2013 Jun 18;110 Suppl 2:10408-15
pubmed: 23754434
BMJ. 2020 Aug 11;370:m3182
pubmed: 32784206
Hum Vaccin Immunother. 2021 Dec 2;17(12):5016-5023
pubmed: 34715002
Int J Environ Res Public Health. 2021 Apr 22;18(9):
pubmed: 33922054
Healthcare (Basel). 2021 Mar 19;9(3):
pubmed: 33808758